Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2017

21.04.2016 | Original Article

NK/T Cell Lymphoma: A Tertiary Centre Experience

verfasst von: Neeraj Arora, Arpan Mehta, Sriram Ravichandran, Indu Arun, Rimpa Basu Achari, Anupam Chakrapani, Saurabh Jayant Bhave, Mammen Chandy, Reena Nair

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Extranodal NK/T-cell lymphoma (ENKTL), nasal type, is a rare type of non-Hodgkin lymphoma that is commonly seen in East Asian countries and is associated with Epstein-Barr virus infection. This is a retrospective study where we describe nine cases of ENKTL; nasal type diagnosed and treated at our center over a period of 2 years. These cases were analyzed retrospectively for clinical presentation (age, sex, site of involvement), immunophenotype, treatment, response and toxicity profile. Sino-nasal symptoms (blocked nose, headache, epistaxis, regurgitation) were the most common presenting complaints (n = 8). Almost 67 % (n = 6/9) of the cases were referred from Bhutan. Necrosis and angiocentricity were the commonest histological features. Depending on the stage of the disease patient were initially treated with chemotherapy (SMILE/CHOP) and Radiotherapy (IFRT). We describe our experience of management of ENKTL, where we observe that Bhutan could be endemic region for this rare tumour.
Literatur
1.
Zurück zum Zitat Au W-Y, Ma S-Y, Chim C-S, Choy C, Loong F, Lie AKW et al (2005) Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the world health organization classification scheme: a single center experience of 10 years. Ann Oncol 16(2):206–214CrossRefPubMed Au W-Y, Ma S-Y, Chim C-S, Choy C, Loong F, Lie AKW et al (2005) Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the world health organization classification scheme: a single center experience of 10 years. Ann Oncol 16(2):206–214CrossRefPubMed
2.
Zurück zum Zitat The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000 50(9):696–702 The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000 50(9):696–702
3.
Zurück zum Zitat Arber DA, Weiss LM, Albújar PF, Chen YY, Jaffe ES (1993) Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17(4):392–399CrossRefPubMed Arber DA, Weiss LM, Albújar PF, Chen YY, Jaffe ES (1993) Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17(4):392–399CrossRefPubMed
4.
Zurück zum Zitat Chim C-S, Ma S-Y, Au W-Y, Choy C, Lie AKW, Liang R et al (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103(1):216–221CrossRefPubMed Chim C-S, Ma S-Y, Au W-Y, Choy C, Lie AKW, Liang R et al (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103(1):216–221CrossRefPubMed
5.
Zurück zum Zitat Cheung MMC, Chan JKC, Lau W, Ngan RKC, Foo WWL (2002) Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54(1):182–190CrossRefPubMed Cheung MMC, Chan JKC, Lau W, Ngan RKC, Foo WWL (2002) Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54(1):182–190CrossRefPubMed
6.
Zurück zum Zitat Yamaguchi M, Kwong Y-L, Kim WS, Maeda Y, Hashimoto C, Suh C et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol Off J Am Soc Clin Oncol. 29(33):4410–4416CrossRef Yamaguchi M, Kwong Y-L, Kim WS, Maeda Y, Hashimoto C, Suh C et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol Off J Am Soc Clin Oncol. 29(33):4410–4416CrossRef
7.
Zurück zum Zitat Shet T, Suryawanshi P, Epari S, Sengar M, Rangarajan V, Menon H et al (2014) Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India. Leuk Lymphoma 55(12):2748–2753CrossRefPubMed Shet T, Suryawanshi P, Epari S, Sengar M, Rangarajan V, Menon H et al (2014) Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India. Leuk Lymphoma 55(12):2748–2753CrossRefPubMed
8.
Zurück zum Zitat Bugalia A, Manipadam MT, Nair S (2013) Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India. Leuk Lymphoma 54(6):1201–1207CrossRefPubMed Bugalia A, Manipadam MT, Nair S (2013) Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India. Leuk Lymphoma 54(6):1201–1207CrossRefPubMed
9.
Zurück zum Zitat Khong P-L, Pang CBY, Liang R, Kwong Y-L, Au W-Y (2008) Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann ≠Hematol 87(8):613–621CrossRefPubMed Khong P-L, Pang CBY, Liang R, Kwong Y-L, Au W-Y (2008) Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann ≠Hematol 87(8):613–621CrossRefPubMed
10.
Zurück zum Zitat Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY et al (2001) CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12(3):349–352CrossRefPubMed Kim WS, Song SY, Ahn YC, Ko YH, Baek CH, Kim DY et al (2001) CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12(3):349–352CrossRefPubMed
11.
Zurück zum Zitat Kwong Y-L, Kim WS, Lim ST, Kim SJ, Tang T, Tse E et al (2012) SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 120(15):2973–2980CrossRefPubMed Kwong Y-L, Kim WS, Lim ST, Kim SJ, Tang T, Tse E et al (2012) SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 120(15):2973–2980CrossRefPubMed
12.
Zurück zum Zitat Li Y-X, Yao B, Jin J, Wang W-H, Liu Y-P, Song Y-W et al (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol. 24(1):181–189CrossRef Li Y-X, Yao B, Jin J, Wang W-H, Liu Y-P, Song Y-W et al (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol. 24(1):181–189CrossRef
13.
Zurück zum Zitat Wang Z-Y, Li Y-X, Wang W-H, Jin J, Wang H, Song Y-W et al (2009) Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood 114(23):4771–4776CrossRefPubMed Wang Z-Y, Li Y-X, Wang W-H, Jin J, Wang H, Song Y-W et al (2009) Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood 114(23):4771–4776CrossRefPubMed
14.
Zurück zum Zitat Koom WS, Chung EJ, Yang W-I, Shim SJ, Suh CO, Roh JK et al (2004) Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59(4):1127–1137CrossRefPubMed Koom WS, Chung EJ, Yang W-I, Shim SJ, Suh CO, Roh JK et al (2004) Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59(4):1127–1137CrossRefPubMed
Metadaten
Titel
NK/T Cell Lymphoma: A Tertiary Centre Experience
verfasst von
Neeraj Arora
Arpan Mehta
Sriram Ravichandran
Indu Arun
Rimpa Basu Achari
Anupam Chakrapani
Saurabh Jayant Bhave
Mammen Chandy
Reena Nair
Publikationsdatum
21.04.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2017
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0675-x

Weitere Artikel der Ausgabe 1/2017

Indian Journal of Hematology and Blood Transfusion 1/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.